在下肢动脉疾病中对克洛皮多格雷尔耐药性的审查
Kerry A Burke1,2,3, John H McDermott1,2, Stuart J Wright4
1Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
JVS-vascular insights
|December 30, 2024
概括
对CYP2C19变异的遗传测试可能会改善服用克洛皮多格雷尔的患者下肢动脉疾病 (LEAD) 的结果. 识别差代谢器可以进行替代疗法,提高治疗效率.
科学领域:
- 血管外科 血管外科
- 药物基因组学 药物基因组学
- 心血管医学 心血管医学
背景情况:
- 下肢动脉疾病 (LEAD) 对健康造成重大负担,增加心血管和四肢事件的风险.
- 克洛皮多格勒是通常推的LEAD抗血小板药物,但其疗效受到CYP2C19遗传变异的影响.
- CYP2C19将克洛皮多格雷尔代谢成其活性形式,遗传多态性可以损害这一过程.
研究的目的:
- 审查关于常规CYP2C19基因测试对患者的实用性相关的文献.
- 评估精准医学策略的潜力,以改善LEAD患者的治疗结果.
主要方法:
- 对现有文献进行了叙事审查.
- 该审查重点研究了LEAD患者中检查CYP2C19基因型和克洛皮多格雷尔反应的研究.
- 考虑在临床实践中实施基因测试.
主要成果:
- 研究表明,CYP2C19功能丧失等位基因与用克洛皮多格雷尔治疗LEAD患者的不良结果之间存在关联.
- 基因定型以识别较差的克洛皮多格雷尔代谢剂,改善了心脏和中风医学的结果.
- 这种方法已经被纳入了其他疾病的国家和国际临床指南.
结论:
- 常规CYP2C19基因检测可能是LEAD患者的宝贵精准医学策略.
- 实施这种策略有可能在这种复杂的患者群体中显著改善临床结果.
- 基于遗传特征的个性化治疗方法可以优化多种并发病患者的治疗.
更多相关视频
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.3K
14:52Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication
Published on: December 11, 2013
11.4K
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
384
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
384
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
528
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
528